Drug intelligence / Profile preview

3-phenylpropionic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

3-phenylpropionic acid is a naturally occurring short-chain carboxylic acid and a gut microbial metabolite derived from dietary polyphenols, phenylalanine, and ferulic acid. It is produced by bacteria such as *Clostridium sporogenes* and *Desulfovibrio piger*. This compound exhibits diverse biological activities, including antimicrobial effects against pathogens like *Salmonella enterica* and *Salmonella pullorum*. It has been shown to reverse insulin resistance and obesity-associated metabolic dysfunction by activating hepatic AMP-activated protein kinase α (AMPKα), leading to insulin-sensitizing and anti-steatotic effects. Furthermore, 3-phenylpropionic acid attenuates intestinal inflammation and damage through the AhR/IL-22/STAT-3 signaling axis and promotes myotube hypertrophy by modulating the Foxo3/NAD+ pathway, inhibiting protein degradation and promoting protein acetylation. It is also implicated in neurological functions, with associations found between its levels and social behavior, ADHD symptoms, and executive function in children. Additionally, it plays a role in plant defense and is used as a fragrance ingredient.

02

Targets

FFAR1 (Free fatty acid receptor 1)AMPK (Adenosine monophosphate–activated protein kinase)FOXO3 (Forkhead box protein O3)

Beyond the preview

Go deeper on 3-phenylpropionic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-phenylpropionic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call